CN115960964A - 一种过表达zxdc慢病毒载体的构建和应用 - Google Patents
一种过表达zxdc慢病毒载体的构建和应用 Download PDFInfo
- Publication number
- CN115960964A CN115960964A CN202211221337.6A CN202211221337A CN115960964A CN 115960964 A CN115960964 A CN 115960964A CN 202211221337 A CN202211221337 A CN 202211221337A CN 115960964 A CN115960964 A CN 115960964A
- Authority
- CN
- China
- Prior art keywords
- zxdc
- plcag
- egfp
- expression
- lentivirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101000784571 Homo sapiens Zinc finger protein ZXDC Proteins 0.000 title claims abstract description 71
- 102100020906 Zinc finger protein ZXDC Human genes 0.000 title claims abstract description 71
- 239000013598 vector Substances 0.000 title claims abstract description 67
- 230000002018 overexpression Effects 0.000 title claims abstract description 24
- 238000010276 construction Methods 0.000 title claims abstract description 13
- 230000014509 gene expression Effects 0.000 claims abstract description 38
- 241000713666 Lentivirus Species 0.000 claims abstract description 28
- 239000013612 plasmid Substances 0.000 claims abstract description 24
- 102000004190 Enzymes Human genes 0.000 claims abstract description 19
- 108090000790 Enzymes Proteins 0.000 claims abstract description 19
- 101100382122 Homo sapiens CIITA gene Proteins 0.000 claims abstract description 18
- 108700002010 MHC class II transactivator Proteins 0.000 claims abstract description 18
- 102100026371 MHC class II transactivator Human genes 0.000 claims abstract description 18
- 238000005520 cutting process Methods 0.000 claims abstract description 13
- 230000002757 inflammatory effect Effects 0.000 claims abstract description 12
- 238000004806 packaging method and process Methods 0.000 claims abstract description 8
- 239000001963 growth medium Substances 0.000 claims description 22
- 238000012163 sequencing technique Methods 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 14
- 238000001976 enzyme digestion Methods 0.000 claims description 12
- 241000700605 Viruses Species 0.000 claims description 11
- 230000001580 bacterial effect Effects 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 238000013518 transcription Methods 0.000 claims description 10
- 230000035897 transcription Effects 0.000 claims description 10
- 230000003321 amplification Effects 0.000 claims description 9
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 9
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 238000012795 verification Methods 0.000 claims description 7
- 230000004913 activation Effects 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 229940088710 antibiotic agent Drugs 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 5
- 230000001131 transforming effect Effects 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 102000018120 Recombinases Human genes 0.000 claims description 3
- 108010091086 Recombinases Proteins 0.000 claims description 3
- 230000001276 controlling effect Effects 0.000 claims description 3
- 230000029087 digestion Effects 0.000 claims description 3
- 230000002025 microglial effect Effects 0.000 claims description 3
- 230000035939 shock Effects 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 31
- 210000000274 microglia Anatomy 0.000 abstract description 19
- 210000003169 central nervous system Anatomy 0.000 abstract description 9
- 238000011160 research Methods 0.000 abstract description 5
- 101150112286 Zxdc gene Proteins 0.000 abstract description 4
- 230000002103 transcriptional effect Effects 0.000 abstract description 3
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 29
- 239000000203 mixture Substances 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 239000002158 endotoxin Substances 0.000 description 11
- 229920006008 lipopolysaccharide Polymers 0.000 description 11
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 10
- 102100040247 Tumor necrosis factor Human genes 0.000 description 10
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 9
- 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 description 9
- 238000001890 transfection Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000006143 cell culture medium Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000012096 transfection reagent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
- 108700013048 CCL2 Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000000018 Chemokine CCL2 Human genes 0.000 description 1
- 102000004480 Cyclin-Dependent Kinase Inhibitor p57 Human genes 0.000 description 1
- 108010017222 Cyclin-Dependent Kinase Inhibitor p57 Proteins 0.000 description 1
- 102100023227 E3 SUMO-protein ligase EGR2 Human genes 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
- 101001049692 Homo sapiens E3 SUMO-protein ligase EGR2 Proteins 0.000 description 1
- 101000784552 Homo sapiens Zinc finger X-linked protein ZXDA Proteins 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100020909 Zinc finger X-linked protein ZXDA Human genes 0.000 description 1
- 210000001642 activated microglia Anatomy 0.000 description 1
- 101150063416 add gene Proteins 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000005758 transcription activity Effects 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
引物 | 序列(5’-3’) | 序列编号 |
F1 | GCTCTAGAGCCTCTGCTAACC | SEQ ID NO.6 |
F2 | GAGTAGACTGTGAGGCTCCTGC | SEQ ID NO.7 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211221337.6A CN115960964A (zh) | 2022-10-08 | 2022-10-08 | 一种过表达zxdc慢病毒载体的构建和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211221337.6A CN115960964A (zh) | 2022-10-08 | 2022-10-08 | 一种过表达zxdc慢病毒载体的构建和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115960964A true CN115960964A (zh) | 2023-04-14 |
Family
ID=87360519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211221337.6A Pending CN115960964A (zh) | 2022-10-08 | 2022-10-08 | 一种过表达zxdc慢病毒载体的构建和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115960964A (zh) |
-
2022
- 2022-10-08 CN CN202211221337.6A patent/CN115960964A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102551324B1 (ko) | Rna-가이드 유전자 편집 및 유전자 조절 | |
KR20190065251A (ko) | 모듈러 AAV 전달 시스템을 통한 CRISPR-Cas 게놈 가공 | |
WO2014145599A2 (en) | Recombinant virus and preparations thereof | |
US11767530B2 (en) | Splice inhibiting oligonucleotides | |
CN114941011B (zh) | 慢病毒载体及其应用 | |
CN111733184B (zh) | 腺病毒包装方法 | |
CN114174520A (zh) | 用于选择性基因调节的组合物和方法 | |
CN112057611A (zh) | 非洲猪瘟病毒e120r蛋白作为免疫抑制剂的应用及免疫抑制位点敲除毒株的构建 | |
CN113278635B (zh) | 一种促进环状rna成环的序列组合及其应用 | |
KR20230129162A (ko) | 제1형 근긴장성 이영양증을 치료하기 위한 rna 표적화조성물 및 방법 | |
KR20230127221A (ko) | Cag 반복 질환을 치료하기 위한 rna 표적화 조성물및 방법 | |
CN113621611A (zh) | 一种髓系特异性启动子及其应用 | |
CN116218844B (zh) | 一种双向启动子及其过表达载体、慢病毒表达质粒和应用 | |
CN115960964A (zh) | 一种过表达zxdc慢病毒载体的构建和应用 | |
CN114934070B (zh) | 间充质干细胞及其抗炎应用 | |
CN109266683B (zh) | 一种包含e4bp4基因的慢病毒重组载体及其制备方法和应用 | |
CN113444744A (zh) | 一种用于基因编辑NK细胞的mRNA模板及构建方法、mRNA的体外转录方法和应用 | |
CN112779262A (zh) | 猪RagC基因的应用 | |
CN113584085B (zh) | 一种针对悬浮细胞的慢病毒载体及其应用 | |
CN112521515B (zh) | Cd19和cd10双靶点嵌合抗原受体及其应用 | |
CN112143756B (zh) | 一种基于AdEasyTM系统的高效重组腺病毒载体的制备方法和应用 | |
CN107881174B (zh) | 一种翻译水平基因表达调控的方法及应用 | |
CN114045305B (zh) | 多转座子系统 | |
CN101709084A (zh) | 优化的串连细胞因子及其在诱导多能性干细胞中的应用 | |
CN112143757A (zh) | 一种糖蛋白muc16原位稳定过表达方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240428 Address after: 518107 No. 66, gongchang Road, Xinhu street, Guangming District, Shenzhen, Guangdong Applicant after: Shenzhen, Zhongshan University Country or region after: China Applicant after: SUN YAT-SEN University Address before: 510275 No. 135 West Xingang Road, Guangzhou, Guangdong, Haizhuqu District Applicant before: SUN YAT-SEN University Country or region before: China |